Successful Extracorporeal Blood Purification Therapy Using Double Haemoadsorption Device in Severe Endotoxin Septic Shock: A Case Report

1Coureuil M, Join-Lambert O, Lécuyer H, Bourdoulous S, Marullo S, Nassif X. Pathogenesis of meningococcemia. Cold Spring Harb Perspect Med. 2013; 3(6):a012393 Coureuil M Join-Lambert O Lécuyer H Bourdoulous S Marullo S Nassif X Pathogenesis of meningococcemia Cold Spring Harb Perspect Med 2013 36a01239310.1101/cshperspect.a012393366235023732856Search in Google Scholar

2Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014; 5(1): 36-44 Wiersinga WJ Leopold SJ Cranendonk DR van der Poll T Host innate immune responses to sepsis Virulence 2014 51 36-4410.4161/viru.25436391638123774844Search in Google Scholar

3Uchino S, Kellum JA, Bellomo R, et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813–818 Uchino S Kellum JA Bellomo R et al Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study JAMA 2005 294 813 81810.1001/jama.294.7.81316106006Search in Google Scholar

4Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls. Crit Care 2018; 22: 262 Ankawi G Neri M Zhang J Breglia A Ricci Z Ronco C Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls Crit Care 2018 22 26210.1186/s13054-018-2181-z620285530360755Search in Google Scholar

5Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018; 44(6):925-928 Levy MM Evans LE Rhodes A The Surviving Sepsis Campaign Bundle: 2018 update Intensive Care Med 2018 446925-92810.1097/CCM.000000000000311929767636Search in Google Scholar

6Hattori N, Oda S. Cytokine-adsorbing hemofilter: old but new modality for septic acute kidney injury. Renal Replacement Therapy 2016; 2(1):41 Hattori N Oda S Cytokine-adsorbing hemofilter: old but new modality for septic acute kidney injury Renal Replacement Therapy 2016 214110.1186/s41100-016-0051-1Search in Google Scholar

7Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018; 6:12 Malard B Lambert C Kellum JA In vitro comparison of the adsorption of inflammatory mediators by blood purification devices Intensive Care Med Exp 2018 61210.1186/s40635-018-0177-2593560129728790Search in Google Scholar

8Shum HP, Chan KC, Kwan MC, Yan WW. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram negative bacterial infection. Hong Kong Med J. 2013; 19 :491–7 Shum HP Chan KC Kwan MC Yan WW Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram negative bacterial infection Hong Kong Med J 2013 19 491 710.12809/hkmj13391023650198Search in Google Scholar

9Turani F, Candidi F, Barchetta R, et al. Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: A clinical experience. Crit Care 2013; 17:S22–3 Turani F Candidi F Barchetta R et al Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: A clinical experience Crit Care 2013 17S22 310.1186/cc12001Search in Google Scholar

10Gruda MC, Ruggeberg KG, O’Sullivan P, et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS One 2018; 13(1): e0191676 Gruda MC Ruggeberg KG O’Sullivan P et al Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads PLoS One 2018 131 e019167610.1371/journal.pone.0191676578493129370247Search in Google Scholar

11Rampino T, Gregorini M, Perotti L, et al. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia. Blood Purif 2021; 50:566-571 Rampino T Gregorini M Perotti L et al Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia Blood Purif 2021 50566 57110.1159/000511725770593933181508Search in Google Scholar

12Napp LC, Lebreton G, De Somer F, Supady A, Pappalardo F. Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO. Artif Organs. 2021; 45(10):1240-1249. Napp LC Lebreton G De Somer F Supady A Pappalardo F Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO Artif Organs 2021 45101240 124910.1111/aor.1402534152637Search in Google Scholar